Skip to Content

NT-0201 Approval Status

  • FDA approved: No
  • Brand name: NT-0201
  • Generic name: amphetamine
  • Dosage form: Extended-Release Liquid Suspension
  • Company: Neos Therapeutics, Inc.
  • Treatment for: ADHD

NT-0201 (amphetamine) is an extended-release liquid suspension amphetamine formulation in development for the treatment of ADHD.

Development Status and FDA Approval Process for NT-0201

Nov 17, 2016Neos Therapeutics Submits NDA for Amphetamine Extended-Release Liquid Suspension Drug Candidate, NT-0201, for the Treatment of ADHD

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.